| pubmed-article:21264122 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21264122 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:21264122 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:21264122 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:21264122 | lifeskim:mentions | umls-concept:C1136254 | lld:lifeskim |
| pubmed-article:21264122 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21264122 | pubmed:dateCreated | 2011-1-25 | lld:pubmed |
| pubmed-article:21264122 | pubmed:abstractText | A series of 2-[2-(2,6-dichlorophenyl)amino]benzyl-3-(5-substituted phenyl-4,5-dihydro-1H-pyrazol-3-yl-amino)-6,8-dibromoquinazolin-4(3H) ones 6a-m have been synthesized by the reaction of 2-[2-(2,6-dichlorophenyl)amino]benzyl-3-substituted phenylacrylamido-6,8-dibromoquinazolin-4(3H) ones 5a-m with hydrazine hydrate in the presence of glacial acetic acid. The chalcones 5a-m were prepared by the condensation of 2-[2-(2,6-dichlorophenyl)amino]benzyl-3-acetamido-6,8-dibromoquinazolin-4(3H)one 4 with different substituted aromatic aldehyde. The benzoxazinone 2 was synthesized from 2-[2-(2,6-dichlorophenyl)amino]phenyl acetyl chloride 1 on treatment with 3,5-dibromoanthranilic acid in pyridine, which on reaction with hydrazine hydrate and then on acetylation reaction yielded 4. The structures of these compounds have been elucidated by elemental analyses, IR, and NMR spectral data. The title compounds pyrazolyl-quinazolin-4(3H)ones 6a-m were evaluated for their antibacterial and antifungal activities in vitro. | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21264122 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21264122 | pubmed:status | PubMed-not-MEDLINE | lld:pubmed |
| pubmed-article:21264122 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21264122 | pubmed:issn | 0975-1505 | lld:pubmed |
| pubmed-article:21264122 | pubmed:author | pubmed-author:PatelNbN | lld:pubmed |
| pubmed-article:21264122 | pubmed:author | pubmed-author:PatelJcJ | lld:pubmed |
| pubmed-article:21264122 | pubmed:author | pubmed-author:BaratGgG | lld:pubmed |
| pubmed-article:21264122 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21264122 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:21264122 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21264122 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21264122 | pubmed:pagination | 173-82 | lld:pubmed |
| pubmed-article:21264122 | pubmed:dateRevised | 2011-7-20 | lld:pubmed |
| pubmed-article:21264122 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:21264122 | pubmed:articleTitle | Synthesis and Antimicrobial Activity of 2-[2-(2,6-dichloro phenyl)amino]benzyl-3-(5-substituted phenyl-4,5-dihydro-1H-pyrazol-3-yl-amino)-6,8-dibromoquinazolin-4(3H)ones. | lld:pubmed |
| pubmed-article:21264122 | pubmed:affiliation | Department of Chemistry, Veer Narmad South Gujarat University, Surat 395007, Gujarat, India. | lld:pubmed |
| pubmed-article:21264122 | pubmed:publicationType | Journal Article | lld:pubmed |
